These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17523276)

  • 1. Is p53 and heat shock protein 70 expression a useful parameter for preoperative hyperthermoradiation therapy in advanced rectal carcinoma.
    Takeuchi K; Nakajima M; Miyazaki T; Ide M; Asao T; Fujita K; Kuwano H
    Hepatogastroenterology; 2007 Mar; 54(74):367-72. PubMed ID: 17523276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer.
    Kitamura K; Saeki H; Kawaguchi H; Araki K; Ohno S; Kuwano H; Maehara Y; Sugimachi K
    Hepatogastroenterology; 2000; 47(32):419-23. PubMed ID: 10791203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival.
    Rosenberg R; Nekarda H; Zimmermann F; Becker K; Lordick F; Hofler H; Molls M; Siewert JR
    J Surg Oncol; 2008 Jan; 97(1):8-13. PubMed ID: 18085619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative diagnosis of locally advanced rectal carcinoma after preoperative therapy].
    Barth C; Rau B; Hünerbein M; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1404-7. PubMed ID: 9931895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
    Klenova A; Georgiev R; Kurtev P; Kurteva G
    J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.
    Chang HJ; Jung KH; Kim DY; Jeong SY; Choi HS; Kim YH; Sohn DK; Yoo BC; Lim SB; Kim DH; Ahn JB; Kim IJ; Kim JM; Yoon WH; Park JG
    Hum Pathol; 2005 Apr; 36(4):364-71. PubMed ID: 15891997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative treatment of rectal cancer with radiation, chemotherapy and hyperthermia: analysis of treatment efficacy and heat-shock response.
    Rau B; Gaestel M; Wust P; Stahl J; Mansmann U; Schlag PM; Benndorf R
    Radiat Res; 1999 Apr; 151(4):479-88. PubMed ID: 10190501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
    Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience.
    Valentini V; Coco C; Rizzo G; Manno A; Crucitti A; Mattana C; Ratto C; Verbo A; Vecchio FM; Barbaro B; Gambacorta MA; Montoro C; Barba MC; Sofo L; Papa V; Menghi R; D'Ugo DM; Doglietto G
    Surgery; 2009 May; 145(5):486-94. PubMed ID: 19375606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
    Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative chemoradiation followed by transanal excision for rectal cancer.
    Huh JW; Jung EJ; Park YA; Lee KY; Sohn SK
    J Surg Res; 2008 Aug; 148(2):244-50. PubMed ID: 17936793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 and DCC immunohistochemistry in curative rectal cancer surgery.
    Morgan M; Koorey D; Painter D; Findlay M; Newland R; Chapuis P; Solomon M
    Int J Colorectal Dis; 2003 May; 18(3):188-95. PubMed ID: 12673482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of P53-immunohistochemistry in large slice in evaluating distal intramural spread extent in rectal cancer].
    Pan ZZ; Wan DS; Zhang CQ; Shao JY; Li LR; Chen G; Zhou ZW; Lu ZH; Wang FL
    Ai Zheng; 2004 Oct; 23(10):1199-202. PubMed ID: 15473935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.